93
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD

, , , , , , & show all
Pages 1689-1703 | Published online: 27 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Shahid Shah, Sameen Abbas, Irfhan Ali Bin Hyder Ali & Ahmad Salman. (2020) The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 661-672.
Read now
Anthony D D’Urzo, Peter Kardos & Russell Wiseman. (2018) Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1089-1104.
Read now
Eleonore H Koolen, Philip J van der Wees, Gert P Westert, Richard Dekhuijzen, Yvonne F Heijdra & Alex J van ’t Hul. (2018) Evaluation of the COPDnet integrated care model in patients with COPD: the study protocol. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2237-2244.
Read now
Eleonore H Koolen, Philip J van der Wees, Gert P Westert, Richard Dekhuijzen, Yvonne F Heijdra & Alex J van ’t Hul. (2018) The COPDnet integrated care model. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2225-2235.
Read now

Articles from other publishers (10)

Elias Saad, Basheer Maamoun & Assy Nimer. (2023) Increased Red Blood Cell Distribution Predicts Severity of Chronic Obstructive Pulmonary Disease Exacerbation. Journal of Personalized Medicine 13:5, pages 843.
Crossref
Chen-Yu Wang, Chen Liu, Hsien-Hui Yang, Pei-Ying Tseng & Jong-Yi Wang. (2022) The Association between Medical Utilization and Chronic Obstructive Pulmonary Disease Severity: A Comparison of the 2007 and 2011 Guideline Staging Systems. Healthcare 10:4, pages 721.
Crossref
Jennifer K. Quint, Jukka Montonen, Daina B. Esposito, Xintong He, Leslie Koerner, Laura Wallace, Alberto de la Hoz & Marc Miravitlles. (2021) Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database. Advances in Therapy 38:5, pages 2249-2270.
Crossref
Bartolome Celli, Nicholas Locantore, Julie C. Yates, Per Bakke, Peter M.A. Calverley, Courtney Crim, Harvey O. Coxson, David A. Lomas, William MacNee, Bruce E. Miller, Hana Mullerova, Stephen I. Rennard, Edwin K. Silverman, Emiel Wouters, Ruth Tal-Singer, Alvar Agusti & Jørgen Vestbo. (2021) Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort. European Respiratory Journal 57:3, pages 2001339.
Crossref
Randy Sorge & Peter DeBlieux. (2020) Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Primer for Emergency Physicians. The Journal of Emergency Medicine 59:5, pages 643-659.
Crossref
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sabariah Noor Harun, Shahid Shah & Sameen Abbas. (2019) The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. The European Journal of Health Economics 21:2, pages 181-194.
Crossref
Suzanne G Bollmeier & Aaron P Hartmann. (2020) Management of chronic obstructive pulmonary disease: A review focusing on exacerbations. American Journal of Health-System Pharmacy 77:4, pages 259-268.
Crossref
Aparna Balasubramanian, Neil R. MacIntyre, Robert J. Henderson, Robert L. Jensen, Gregory Kinney, William W. Stringer, Craig P. Hersh, Russell P. Bowler, Richard Casaburi, MeiLan K. Han, Janos Porszasz, R. Graham Barr, Barry J. Make, Robert A. Wise & Meredith C. McCormack. (2019) Diffusing Capacity of Carbon Monoxide in Assessment of COPD. Chest 156:6, pages 1111-1119.
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) Chronic Obstructive Pulmonary Disease Exacerbations: A Need for Action. The American Journal of Medicine 131:9, pages 15-22.
Crossref
Valerie G. Press, R. Tamara Konetzka & Steven R. White. (2018) Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program. Current Opinion in Pulmonary Medicine 24:2, pages 138-146.
Crossref